RAPT Therapeutics Inc — Quarterly Cash Flow (NASDAQ:RAPT) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Total assets 108.47 M240.32 M187.57 M178.41 M165.74 M Total liabilities 12.96 M50.42 M10.2 M14 M13.76 M Total equity 95.51 M189.9 M177.37 M164.41 M151.98 M Total liabilities & shareholders' equities 108.47 M240.32 M187.57 M178.41 M165.74 M Total debt ————— Net debt —————

Haberler

GSK, RAPT Therapeutics’i 2,2 milyar dolara satın aldı

GSK completes $2.2 billion acquisition of RAPT Therapeutics

RAPT Therapeutics hissesi 57,98 dolarla zirve yaptı

RAPT Therapeutics stock hits 52-week high at $57.98

Rapt Therapeutics hisseleri 57,87 dolar ile 52 haftalık zirveye ulaştı

Rapt Therapeutics stock hits 52-week high at 57.87 USD

Laboratuvardan Ralliye: Wells Fargo, SMID-Cap Biyoteknolojide 2026’nın En İyi Hisselerini Seçti

Rapt Therapeutics hisseleri 57,71 dolar ile 52 haftalık zirveye ulaştı

Rapt Therapeutics stock reaches 52-week high at $57.71

GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout

Rapt Therapeutics hisseleri 57,62 dolar ile 52 haftalık zirveye ulaştı

Rapt Therapeutics stock hits 52-week high at $57.62